182 related articles for article (PubMed ID: 7562567)
1. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.
Broening HW; Bowyer JF; Slikker W
J Pharmacol Exp Ther; 1995 Oct; 275(1):325-33. PubMed ID: 7562567
[TBL] [Abstract][Full Text] [Related]
2. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.
Broening HW; Bacon L; Slikker W
J Pharmacol Exp Ther; 1994 Oct; 271(1):285-93. PubMed ID: 7965726
[TBL] [Abstract][Full Text] [Related]
3. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
Miller DB; O'Callaghan JP
Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
[TBL] [Abstract][Full Text] [Related]
4. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
5. Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.
Lizarraga LE; Phan AV; Cholanians AB; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2014 Jun; 139(2):421-31. PubMed ID: 24595820
[TBL] [Abstract][Full Text] [Related]
6. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
7. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.
Malberg JE; Seiden LS
J Neurosci; 1998 Jul; 18(13):5086-94. PubMed ID: 9634574
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
Orio L; O'Shea E; Sanchez V; Pradillo JM; Escobedo I; Camarero J; Moro MA; Green AR; Colado MI
J Neurochem; 2004 Jun; 89(6):1445-53. PubMed ID: 15189347
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain.
Escobedo I; Peraile I; Orio L; Colado MI; O'Shea E
J Neurochem; 2007 Jun; 101(5):1272-83. PubMed ID: 17328712
[TBL] [Abstract][Full Text] [Related]
11. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
12. Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats.
Shokry IM; Shields CJ; Callanan JJ; Ma Z; Tao R
BMC Pharmacol Toxicol; 2019 Aug; 20(1):47. PubMed ID: 31383036
[TBL] [Abstract][Full Text] [Related]
13. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.
Cappon GD; Morford LL; Vorhees CV
Brain Res Dev Brain Res; 1997 Nov; 103(2):155-62. PubMed ID: 9427479
[TBL] [Abstract][Full Text] [Related]
15. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
Durkin S; Prendergast A; Harkin A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
[TBL] [Abstract][Full Text] [Related]
16. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
17. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Piper BJ; Ali SF; Daniels LG; Meyer JS
Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
[TBL] [Abstract][Full Text] [Related]
18. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
[TBL] [Abstract][Full Text] [Related]
19. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
Goñi-Allo B; Puerta E; Mathúna BO; Hervias I; Lasheras B; de la Torre R; Aguirre N
Neuropharmacology; 2008 Apr; 54(5):885-900. PubMed ID: 18329670
[TBL] [Abstract][Full Text] [Related]
20. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]